Tyme Technologies logo
Tyme Technologies TYME

Quarterly report 2022-Q2
added 08-09-2022

report update icon

Tyme Technologies Long Term Debt Current 2011-2026 | TYME

Annual Long Term Debt Current Tyme Technologies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
34.7 K 54.7 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
54.7 K 34.7 K 44.7 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.9 4.56 % $ 9.38 B australiaAustralia
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 319.85 -4.06 % $ 41.9 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
3.58 M $ 7.58 2.1 % $ 74.9 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 21.82 0.65 % $ 1.02 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 101.59 2.13 % $ 27.2 B germanyGermany
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.49 2.69 % $ 351 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.07 -3.15 % $ 5.05 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
671 K - -5.16 % $ 5.39 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.37 -11.94 % $ 352 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.28 0.94 % $ 458 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.04 -2.2 % $ 3.06 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.59 6.81 % $ 423 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Caladrius Biosciences Caladrius Biosciences
CLBS
137 K - -16.75 % $ 25.8 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
364 K - - $ 25.3 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 33.68 -0.56 % $ 2.24 B usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA